A Minimum of 150 consecutive patients of decompensated cirrhosis of any etiology, presenting to the Institute of Liver and Biliary Sciences hospital with a diagnosis of difficult to treat SBP will be included and randomized into two treatment groups. Group A - Carbepenem+albumin Group B - Carbepenem+albumin+GMCSF.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
146
Institute of Liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi, India
Total no of patients cured from SBP (Spontaneous Bacterial Peritonitis)
Time frame: 1 week
Survival at week 2
Time frame: week 2
Survival at week 4
Time frame: week 4
Survival at week 12
Time frame: week 12
Total number of patients develop variceal bleed.
Time frame: 1 week
Total number of patients develop non-SBP (Spontaneous Bacterial Peritonitis) infections within 1 wk of enrolment.
Time frame: 1 week
Total number of patients develop HE (Hepatic Encephalopathy).
Time frame: 1 week
Total number of patients develop AKI (Acute kidney Injury).
Time frame: 1 week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.